BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 24789501)

  • 21. PD-1 Blockade Can Restore Functions of T-Cells in Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma In Vitro.
    Quan L; Chen X; Liu A; Zhang Y; Guo X; Yan S; Liu Y
    PLoS One; 2015; 10(9):e0136476. PubMed ID: 26361042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinicopathological features of Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly].
    Xu FP; Liu YH; Zhuang HG; Luo DL; Li L; Zhang F; Luo XL; Du X; Li WY; Chen Q
    Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):616-21. PubMed ID: 22177246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevalence and clinico-pathological characteristics in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma in a high complexity hospital in Cali, Columbia].
    Amaya D; Moreno JC; Calvache N; Castro A; Pérez B; Silva N
    Rev Esp Patol; 2019; 52(3):139-146. PubMed ID: 31213254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Europe expression of EBNA2 is associated with poor survival in EBV-positive diffuse large B-cell lymphoma of the elderly.
    Stuhlmann-Laeisz C; Borchert A; Quintanilla-Martinez L; Hoeller S; Tzankov A; Oschlies I; Kreuz M; Trappe R; Klapper W
    Leuk Lymphoma; 2016; 57(1):39-44. PubMed ID: 25899404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management.
    Castillo JJ; Beltran BE; Miranda RN; Young KH; Chavez JC; Sotomayor EM
    Am J Hematol; 2016 May; 91(5):529-37. PubMed ID: 27093913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex.
    Ayoubian H; Ludwig N; Fehlmann T; Menegatti J; Gröger L; Anastasiadou E; Trivedi P; Keller A; Meese E; Grässer FA
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
    Wang E; Papavassiliou P; Sebastian S
    Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.
    Kinch A; Baecklund E; Backlin C; Ekman T; Molin D; Tufveson G; Fernberg P; Sundström C; Pauksens K; Enblad G
    Acta Oncol; 2014 May; 53(5):669-79. PubMed ID: 24164103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TET2 and LILRB1 mutations are frequent in Epstein-Barr virus-positive diffuse large B-cell lymphoma especially in elderly patients.
    Cho J; Kim E; Yoon SE; Kim SJ; Kim WS
    Cancer; 2023 May; 129(10):1502-1512. PubMed ID: 36812290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reappraisal of Epstein-Barr virus (EBV) in diffuse large B-cell lymphoma (DLBCL): comparative analysis between EBV-positive and EBV-negative DLBCL with EBV-positive bystander cells.
    Ohashi A; Kato S; Okamoto A; Inaguma Y; Satou A; Tsuzuki T; Emi N; Okamoto M; Nakamura S
    Histopathology; 2017 Jul; 71(1):89-97. PubMed ID: 28231401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.
    Morishima S; Nakamura S; Yamamoto K; Miyauchi H; Kagami Y; Kinoshita T; Onoda H; Yatabe Y; Ito M; Miyamura K; Nagai H; Moritani S; Sugiura I; Tsushita K; Mihara H; Ohbayashi K; Iba S; Emi N; Okamoto M; Iwata S; Kimura H; Kuzushima K; Morishima Y
    Leuk Lymphoma; 2015 Apr; 56(4):1072-8. PubMed ID: 24975317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue markers of Epstein-Bar virus (EBV) infection in B-cell non-Hodgkin's lymphomas.
    Kasprzak A; Spachacz R; Hałoń A; Jeleń M; Stefańska K; Wachowiak J; Trejster E; Zabel M
    Med Wieku Rozwoj; 2006; 10(3 Pt 1):639-48. PubMed ID: 17317895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age.
    Lu TX; Liang JH; Miao Y; Fan L; Wang L; Qu XY; Cao L; Gong QX; Wang Z; Zhang ZH; Xu W; Li JY
    Sci Rep; 2015 Jul; 5():12168. PubMed ID: 26202875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presence of EBV antigens detected by a sensitive method in pediatric and adult Diffuse Large B-cell lymphomas.
    Mangiaterra TS; De Dios Soler M; Oviedo N; Colli S; Preciado MV; Soria M; Galluzo L; De Matteo E; Chabay P
    Int J Cancer; 2023 Sep; 153(5):1043-1050. PubMed ID: 37318089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary nasopharyngeal non-Hodgkin lymphoma and its relationship with Epstein-Barr virus infection.
    Zhang B; Zong Y; He J; Zhong B; Lin S
    Chin Med J (Engl); 2003 Jun; 116(6):913-7. PubMed ID: 12877806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone deacetylase inhibitor romidepsin induces efficient tumor cell lysis via selective down-regulation of LMP1 and c-myc expression in EBV-positive diffuse large B-cell lymphoma.
    Shin DY; Kim A; Kang HJ; Park S; Kim DW; Lee SS
    Cancer Lett; 2015 Aug; 364(2):89-97. PubMed ID: 25790907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Common and HIV-related diffuse large B-cell lymphomas differ in their immunoglobulin gene mutation pattern.
    Delecluse HJ; Hummel M; Marafioti T; Anagnostopoulos I; Stein H
    J Pathol; 1999 Jun; 188(2):133-8. PubMed ID: 10398155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a clinicopathological study of 14 Epstein-Barr virus-positive cases.
    Elsayed AA; Satou A; Eladl AE; Kato S; Nakamura S; Asano N
    Histopathology; 2017 Mar; 70(4):579-594. PubMed ID: 27735994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A20 (TNFAIP3) deletion in Epstein-Barr virus-associated lymphoproliferative disorders/lymphomas.
    Ando M; Sato Y; Takata K; Nomoto J; Nakamura S; Ohshima K; Takeuchi T; Orita Y; Kobayashi Y; Yoshino T
    PLoS One; 2013; 8(2):e56741. PubMed ID: 23418597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations.
    Hoeller S; Tzankov A; Pileri SA; Went P; Dirnhofer S
    Hum Pathol; 2010 Mar; 41(3):352-7. PubMed ID: 19913281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.